Overcoming roadblocks in the development of vaccines for leishmaniasis.
Paul M KayeSakshi MohanCarsten MantelMelissa MalhamePaul RevillEpke Le RutteVivak ParkashAlison M LaytonCharles J N LaceyStefano MalvoltiPublished in: Expert review of vaccines (2021)
Despite significant progress, leishmaniasis vaccine development remains hindered by significant gaps in understanding that span the vaccine development pipeline. Increased coordination and adoption of a more holistic view to vaccine development will be required to ensure more rapid progress in the years ahead.
Keyphrases